4LL:F:F-Teladoc Inc (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 8.109

Change

+0.61 (+8.12)%

Market Cap

USD 1.34B

Volume

449.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

-1.41 (-1.68%)

USD 38.43B
4YC:F M3 INC.

+0.15 (+1.72%)

USD 6.36B
2HE:F Healthequity Inc

+2.00 (+2.82%)

USD 6.07B
6HL0:F R1 RCM Inc

+0.10 (+0.80%)

USD 5.35B
9EH:F Evolent Health Inc

-1.00 (-3.82%)

USD 3.05B
1KJ:F 10X GENOMICS DL -00001

+0.31 (+1.57%)

USD 2.56B
6JM:F JMDC INC.

+0.40 (+1.42%)

USD 1.91B
OC9:F Omnicell Inc

+0.60 (+1.58%)

USD 1.77B
1XZ:F Ping An Healthcare and Technol..

-0.07 (-3.99%)

USD 1.34B
19P:F Phreesia Inc

+0.20 (+0.99%)

USD 1.18B

ETFs Containing 4LL:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -59.16% 18% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -59.16% 17% F 6% D-
Trailing 12 Months  
Capital Gain -53.93% 22% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -53.93% 22% F 9% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -39.67% N/A N/A 1% F
Dividend Return -39.67% N/A N/A 1% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 28.09% N/A N/A 46% F
Risk Adjusted Return -141.22% N/A N/A N/A F
Market Capitalization 1.34B 87% B+ 62% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector